XML 46 R3.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Unaudited Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Revenues $ 17,915 $ 14,134 $ 45,697 $ 41,618
Cost of revenues 16,329 10,398 38,770 30,364
Gross margin 1,586 3,736 6,927 11,254
Operating expenses:        
Research and development 2,049 2,470 6,920 7,573
Selling, general and administrative 6,071 5,347 16,726 16,308
Amortization of acquisition-related intangibles 85 85 255 255
Restructuring 0 47 0 450
Gain on Sinovel settlement, net 0 (24,978) 0 (53,698)
Total operating expenses 8,205 (17,029) 23,901 (29,112)
Operating (loss) income (6,619) 20,765 (16,974) 40,366
Change in fair value of warrants 556 (2,475) 4,648 (2,658)
Gain on sale of minority interest 0 127 0 127
Interest income, net 262 336 1,101 769
Other (expense) income, net (932) 124 45 1,058
(Loss) income before income tax expense (6,733) 18,877 (11,180) 39,662
Income tax expense 112 1,584 29 4,548
Net (loss) income $ (6,845) $ 17,293 $ (11,209) $ 35,114
Net (loss) income per common share        
Basic (in dollars per share) $ (0.32) $ 0.85 $ (0.54) $ 1.73
Diluted (in dollars per share) $ (0.35) $ 0.83 $ (0.75) $ 1.71
Weighted average number of common shares outstanding        
Basic (in shares) 21,185 20,419 20,786 20,300
Diluted (in shares) 21,203 20,864 20,894 20,538